Liang W - Search Results

1

A single-molecule study of the inhibition effect of Naringenin on transforming growth factor-β ligand-receptor binding.

Yang Y, Xu Y, Xia T, Chen F, Zhang C, Liang W, Lai L, Fang X. Yang Y, et al. Among authors: liang w. Chem Commun (Camb). 2011 May 21;47(19):5440-2. doi: 10.1039/c1cc10778j. Epub 2011 Apr 8. Chem Commun (Camb). 2011. PMID: 21475751

2

Smad3 specific inhibitor, naringenin, decreases the expression of extracellular matrix induced by TGF-beta1 in cultured rat hepatic stellate cells.

Liu X, Wang W, Hu H, Tang N, Zhang C, Liang W, Wang M. Liu X, et al. Among authors: liang w. Pharm Res. 2006 Jan;23(1):82-9. doi: 10.1007/s11095-005-9043-5. Epub 2006 Dec 14. Pharm Res. 2006. PMID: 16341574

3

siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene.

Zhang C, Tang N, Liu X, Liang W, Xu W, Torchilin VP. Zhang C, et al. Among authors: liang w. J Control Release. 2006 May 15;112(2):229-39. doi: 10.1016/j.jconrel.2006.01.022. Epub 2006 Mar 20. J Control Release. 2006. PMID: 16545478 Free PMC article.

4

[Cell penetrating peptides enhance intracellular translocation and function of siRNA encapsulated in Pegylated liposomes].

Wang W, Tang N, Zhang CL, Liu XJ, Hu H, Zhang ZX, Liang W. Wang W, et al. Among authors: liang w. Yao Xue Xue Bao. 2006 Feb;41(2):142-8. Yao Xue Xue Bao. 2006. PMID: 16671545 Chinese.

5

Pegylated phospholipids-based self-assembly with water-soluble drugs.

Wang Y, Wang R, Lu X, Lu W, Zhang C, Liang W. Wang Y, et al. Among authors: liang w. Pharm Res. 2010 Feb;27(2):361-70. doi: 10.1007/s11095-009-0029-6. Epub 2009 Dec 22. Pharm Res. 2010. PMID: 20033475

6

Hydroxypropyl-β-cyclodextrin copolymers and their nanoparticles as doxorubicin delivery system.

Wang T, Zhang C, Liang XJ, Liang W, Wu Y. Wang T, et al. Among authors: liang xj, liang w. J Pharm Sci. 2011 Mar;100(3):1067-79. doi: 10.1002/jps.22352. Epub 2010 Oct 4. J Pharm Sci. 2011. PMID: 20922814

7

Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells.

Wang J, Qu H, Jin L, Zeng W, Qin L, Zhang F, Wei X, Lu W, Zhang C, Liang W. Wang J, et al. Among authors: liang w. J Pharm Sci. 2011 Jun;100(6):2267-77. doi: 10.1002/jps.22461. Epub 2011 Jan 18. J Pharm Sci. 2011. PMID: 21246559

8

Naringenin reduces lung metastasis in a breast cancer resection model.

Qin L, Jin L, Lu L, Lu X, Zhang C, Zhang F, Liang W. Qin L, et al. Among authors: liang w. Protein Cell. 2011 Jun;2(6):507-16. doi: 10.1007/s13238-011-1056-8. Epub 2011 Jul 12. Protein Cell. 2011. PMID: 21748601 Free PMC article.

9

Stability influences the biodistribution, toxicity, and anti-tumor activity of doxorubicin encapsulated in PEG-PE micelles in mice.

Wei X, Wang Y, Zeng W, Huang F, Qin L, Zhang C, Liang W. Wei X, et al. Among authors: liang w. Pharm Res. 2012 Jul;29(7):1977-89. doi: 10.1007/s11095-012-0725-5. Epub 2012 Mar 17. Pharm Res. 2012. PMID: 22426964

10

Nanoparticle delivery strategies to target doxorubicin to tumor cells and reduce side effects.

Wang Y, Wei X, Zhang C, Zhang F, Liang W. Wang Y, et al. Among authors: liang w. Ther Deliv. 2010 Aug;1(2):273-87. doi: 10.4155/tde.10.24. Ther Deliv. 2010. PMID: 22816133 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,910 results

Search Page

Filters